Projects

Cardiovascular Morbidity in Pediatric Chronic Kidney Disease: A cross-sectional study of children with Stage 2-5 CKD, on maintenance dialysis and post kidney transplant

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2024 - 2026

Project Lead

Priya Pais

Authors

Priya Pais

Project Status

ongoing